Cardiac Biomarker Diagnostic Kits Market Value to Reach US$ 3.5 Billion by 2027, As per Report by Transparency Market Research, Inc.

Transparency Market Research's most recent report on the Global 𝐂𝐚𝐫𝐝𝐢𝐚𝐜 𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐊𝐢𝐭𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 forecasts a significant growth trajectory driven by the escalating prevalence of cardiovascular disorders worldwide and advancements in novel technologies. The report covers the historical period of 2017-2018 and projects trends for 2019-2027.

The global market for cardiac biomarker diagnostic kits was valued at US$ 2.2 billion in 2018. It is expected to exhibit a compound annual growth rate (CAGR) of 5.2% to reach valuation of around US$ 3.5 Bn from 2019 to 2027, fueled by the increasing demand for effective diagnostic solutions in the cardiovascular healthcare sector.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=62931&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

𝐑𝐢𝐬𝐢𝐧𝐠 𝐩𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞 𝐨𝐟 𝐜𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬 𝐚𝐜𝐫𝐨𝐬𝐬 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐞 : 𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫

The increasing prevalence of cardiovascular disorders worldwide is a primary driver for the global cardiac biomarker diagnostic kits market.

According to the World Health Organization (WHO), approximately 17.9 million people succumb to cardiovascular diseases annually, representing about 31% of all global deaths.

Technological advancements are encouraging patients to seek easy-to-use and portable medical devices, contributing to the market's expansion.

Government funding for cardiovascular disease treatment, emphasis on early detection to monitor heart conditions, and the integration of cardiology with information technology are further propelling the growth of the global cardiac biomarker diagnostic kits market.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Abbott Laboratories,F. Hoffmann-La Roche Ltd.,Danaher Corporation,Siemens Healthineers,bioMérieux SA,Ortho Clinical Diagnostics,Thermo Fisher Scientific, Inc.,Bio-Rad Laboratories, Inc.,among others

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

Product

Troponin Test Kits
CK-MB Test Kits
Myoglobin Test Kits
BNP Test Kits
C-reactive Protein (hsCRP)
Other Biomarkers

Application

Angina Pectoris
Myocardial Infarction (MI)
Cardiac Heart Failure
Others

Testing

Laboratory Testing
Point-of-care Testing

End-user

Hospitals
Clinics
Diagnostic Laboratory

𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐚𝐫𝐝𝐢𝐚𝐜 𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐊𝐢𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

In April 2019, US FDA has approved Ortho Clinical Diagnostics VITROS XT MicroSlides which features new, multi-test technology that allows labs to run two tests simultaneously on one MicroSlide

In September 2018, Abbott receives CE Mark for first troponin test to help predict the chance of heart attack in apparently healthy adults potentially months to years in advance.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬

Drivers:

Increasing prevalence of cardiovascular diseases.
Technological advancements in cardiac biomarker testing.
Growing geriatric population.
Rising demand for point-of-care testing.

Challenges:

Stringent regulatory requirements.
High cost associated with diagnostic tests.
Limited access to healthcare in rural areas.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬

Adoption of high-sensitivity cardiac biomarker assays for early detection.
Growing focus on personalized medicine and precision diagnostics.
Integration of artificial intelligence and machine learning in diagnostic algorithms.
Expansion of product portfolios by key market players through strategic collaborations and acquisitions.

𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐈𝐧𝐬𝐭𝐚𝐧𝐭𝐥𝐲:
https://www.transparencymarketresearch.com/checkout.php?rep_id=62931<ype=S&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐚𝐫𝐝𝐢𝐚𝐜 𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐊𝐢𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐝𝐨𝐦𝐢𝐧𝐚𝐭𝐞𝐝 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭

The cardiac biomarker diagnostic kits market is segmented by region, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

North America dominates the market share globally, driven by factors such as a significant patient population with cardiac diseases, the expansion of high-sensitive cardiac biomarkers, increased adoption of point-of-care instruments by hospitals and clinics, technological advancements, and the development of high sensitivity point-of-care testing.

Meanwhile, the Asia-Pacific region emerges as the most lucrative market during the forecast period from 2019 to 2027. This growth is attributed to developing healthcare infrastructure, a large patient population, increased funding and investment towards cardiac analyzer development, and the heightened focus of both international and domestic players in the region.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬

Assessment of market dynamics, including drivers, challenges, and trends.
Analysis of market segmentation based on various parameters.
Evaluation of regional market landscapes and growth opportunities.
Examination of competitive landscape and key market players.
Identification of strategic initiatives and recent developments shaping the market.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐖𝐚𝐫𝐞𝐡𝐨𝐮𝐬𝐞 𝐑𝐨𝐛𝐨𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/01/23/2593468/0/en/Warehouse-Robotics-Market-to-Grow-at-a-CAGR-of-8-9-during-the-Forecast-Period-Reveals-2023-TMR-Study.html

𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐓𝐰𝐢𝐧 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/01/23/2593341/0/en/Digital-Twin-in-Healthcare-Market-to-Expand-at-CAGR-of-25-1-from-2022-to-2031-according-to-Transparency-Market-Research-Inc.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email:  sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.